Last $58.58 USD
Change Today +0.0045 / 0.01%
Volume 3.7M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 2:28 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Raymond V. Gilmartin

Special Adviser to Executive Committee, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 98 board members in 5 different organizations across 6 different industries.

See Board Relationships
73--

Background*

Mr. Raymond V. Gilmartin, also known as Ray serves as a Special Advisor to the Executive Committee of Merck & Co. Inc. Mr. Gilmartin served as the President of International Federation at Pharmaceutical Manufacturers Associations. Mr. Gilmartin served as Chief Executive Officer and President of Merck & Co. Inc. from June 1994 to May 5, 2005. He joined Becton Dickinson and Company in 1976 as a Vice President of strategic Planning and served as its Chief Executive Officer, ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Trustee
1993-Present
Director
1994-N/A
Special Adviser to Executive Committee
1997-Present
Independent Director, Chairman of Corporate Governance Committee and Member of Compensation Committee
2001-2012
Former Director, Chairman of Governance & Nominating Committee and Member of Regulatory & Public Policy Committee
2013-Present
Director

Education*

MBA 1968
Harvard Business School
BS 1963
Union College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $58.60 USD +0.015

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.